Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled study in Swedish children and adolescents

European Child and Adolescent Psychiatry

Volumn 18, Issue 12, 2009, Pages 725-735

  Svanborg, Pär ^a,b   Thernlund, Gunilla ^c   Gustafsson, Per A ^d   Hägglöf, Bruno ^e   Schacht, Alexander ^f   Kadesjö, Björn ^g  

^a Box 721   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

^f LILLY DEUTSCHLAND GMBH   (Germany)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

ADHD; Atomoxetine; Broader efficacy; CHIP CE; Quality of life

Indexed keywords

ATOMOXETINE; PLACEBO;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD HEALTH CARE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPING BEHAVIOR; DECREASED APPETITE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EDUCATION PROGRAM; FAMILY COPING; FATIGUE; FEMALE; HEADACHE; HEALTH PROGRAM; HUMAN; MALE; PATIENT ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PSYCHOEDUCATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; SELF CONCEPT; SELF ESTEEM;

ACHIEVEMENT; ADAPTATION, PSYCHOLOGICAL; ADRENERGIC UPTAKE INHIBITORS; ATTENTION DEFICIT AND DISRUPTIVE BEHAVIOR DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CAREGIVERS; CHILD; CHILD REARING; COMBINED MODALITY THERAPY; COST OF ILLNESS; DOUBLE-BLIND METHOD; EDUCATION; FAMILY CONFLICT; FEMALE; HARM REDUCTION; HUMANS; MALE; PARENTING; PROPYLAMINES; QUALITY OF LIFE; SELF CONCEPT; SWEDEN;

EID: 70449532246     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-009-0031-x     Document Type: Article

References (41)

1. EM Airaksinen K Michelsson V Jokela 2004 The occurrence of inattention, hyperactivity, impulsivity and coexisting symptoms in a population study of 471 6-8 year old children based on the FTF (Five to fifteen) questionnaire Eur Child Adolesc Psychiatry 13 Suppl 3 III/23 III/30 10.1007/s00787-004-3004-0
2. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders. DSM-IV-TR, Washington DC
3. Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen H-C, Sonuga-Barke EJS, Taylor E (2006) Long-acting medication for the hyperkinetic disorders. A systematic review and European treatment guidelines. Eur Child Adolesc Psychiatry. doi: 10.1007/s00787-006-0549-0 (Pubitemid 46020533)
4. RA Barkley 2002 Psychosocial treatments for attention-deficit/ hyperactivity disorder in children J Clin Psychiatry 63 Suppl 12 36 43 12562060
5. Bernet W, Dulcan MK, Greenhill LL, Pliszka SR (2004) AACAP-endorsed managing: attention-deficit/hyperactivity disorder. Guidelines (Pocketcard) version 2.0 American Academy of Child and Adolescent Psychiatry. International Guidelines Center. Available at http://www.myguidelinescenter.com
6. J Biederman T Spencer T Wilens 2004 Evidence-based pharmacotherapy for the attention-deficit hyperactivity disorder Int J Neuropsychopharmcol 7 77 97 10.1017/S1461145703003973 1:CAS:528:DC%2BD2cXhtlKgs7c%3D (Pubitemid 38523811)
7. RT Brown A Perewien DE Faries CJ Kratochvil BS Vaughan 2006 Atomoxetine in the management of children with ADHD: effect on quality of life and school functioning Clin Pediatr 45 819 827 10.1177/0009922806294219 (Pubitemid 44570029)
8. B Bruce G Thernlund U Nettelbladt 2006 ADHD and language impairment. A study of the parent questionnaire FTF (Five to fifteen) Eur Child Adolesc Psychiatry 15 52 60 10.1007/s00787-006-0508-9 16514510 (Pubitemid 43333719)
9. SA Clarke C Eiser 2004 The measurement of health-related quality of life (QoL) in paediatric clinical trials: a systematic overview Health Qual Life Outcomes 2 66 10.1186/1477-7525-2-66 15555077 (Pubitemid 40472017)
10. Cunningham CE (1997) Readiness for change: applications to the design and evaluation of interventions for children with ADHD. The ADHD Report 5:6-9
11. CE Cunningham RB Bremner M Boyle 1995 Large group community-based parenting programs for families of preschoolers at risk for disruptive behaviour disorders: utilization, cost effectiveness, and outcome J Child Psychol Psychiatr 36 1141 1159 10.1111/j.1469-7610.1995.tb01362.x 1:STN:280: DyaK287hsF2qsA%3D%3D
12. Cunningham CE, Bremner RB, Secord-Gilbert M (2000) COPE: The Community Parent Education Program: a school based family systems oriented workshop for parents of children with disruptive behavior disorders (Leader's manual). COPE Works, Hamilton
13. M Dankaerts E Heplinstall O Chadwick E Taylor 1999 Self report of attention deficit and hyperactivity in adolescents Psychopathology 32 2 81 92 10.1159/000029071 (Pubitemid 29090027)
14. Escobar R, Montoya A, Polavieja P, Cardo E, Artigas J, Hervas A, Fuentes J (2009) Evaluation of patients' and parents' quality of life evaluation in a randomized placebo-controlled atomoxetine study in ADHD. J Child Adolesc Psychopharm (in press)
15. R Escobar CA Soutullo A Hervas X Gastaminza P Polavieja I Gilaberte 2005 Worse quality of life for children with newly diagnosed attention-deficit/ hyperactivity disorder, compared with asthmatic and healthy children Pediatrics 116 364 369 10.1542/peds.2005-0386 (Pubitemid 44336649)
16. Harter S (1985) Manual for the self-perception profile for children. University of Denver Press, Denver
17. B Kadesjö L-O Janols M Korkman K Mickelsson G Strand A Trillingsgaard C Gillberg 2004 The FTF (Five to Fifteen): the development of a parent questionnaire for the assessment of ADHD and comorbid conditions Eur Child Adolesc Psychiatry 13 Suppl 3 III/3 III/13 10.1007/s00787-004-3002-2
18. C Kadesjö H Stenlund P Wels C Gillberg B Hägglöf 2002 Appraisals of stress in child-rearing in Swedish mothers pre-schoolers with ADHD Eur Child Adolesc Psychiatry 11 185 195 10.1007/s00787-002-0281-3 10.1007/s00787-002-0281-3 12444428 (Pubitemid 35429339)
19. J Kaufman B Birmaher D Brent U Rao C Flynn P Moreci D Williamson N Ryan 1997 Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data J Am Acad Child Adolesc Psychiatry 36 7 980 989 10.1097/00004583-199707000-00021 1:STN:280:DyaK2szkvVKqsQ%3D%3D 9204677
20. Landgraf JM, Abetz L, Ware JE (1999) The CHQ user's manual. HealthAct, Boston
21. JM Landgraf E Maunsell K Nixon Speechley M Bullinger S Campbell L Abetz JE Ware 1998 Canadian-French, German and UK versions of the child health questionnaire: methodology and preliminary item scaling results Qual Life Res 7 433 445 10.1023/A:1008810004694 1:STN:280:DyaK1czls1OmsA%3D%3D 9691723 (Pubitemid 28343452)
22. LS Matza AM Rentz K Secnik AR Swensen DA Revicki D Michelson T Spencer JH Newcorn CJ Kratochvil 2004 The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder Dev Behav Pediatr 25 3 166 174 10.1097/00004703-200406000-00005 (Pubitemid 38960833)
23. D Michelson AJ Allen J Busner C Casat D Dunn C Kratochvil J Newcorn FR Sallee RB Sangal K Saylor S West D Kelsey J Wenicke NJ Trapp D Harder 2002 Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study Am J Psychiatry 159 1896 1901 10.1176/appi.ajp.159.11.1896 12411225 (Pubitemid 35283256)
24. Michelson D, Faries DE, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T, The Atomoxetine ADHD Study Group (2001) Atomoxetine in treatment of children and adolescents with attention deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 108(5):e83 (1-9)
25. Myrén K-J, Thernlund G, Nylén Å, Schacht A, Svanborg P (2009) Atomoxetine's effects on societal costs in Sweden. J Attention Dis. doi: 10.1177/1087054709332163
26. NICE (2006) http://www.nice.org.uk/guidance/index.jsp?action=byID&o= 11572
27. Ouvinen-Birgerstam P (1985) I think I am: Jag tycker jag är: manual (Swedish). Psykologiförlaget Stockholm 1985
28. Patterson GR, Chamberlain P (1992) A functional analysis of resistance (A neobehavioral perspective). In: Akowitz H (ed) Why don't people change? New perspectives on resistance and noncompliance. Guilford Press, New York
29. AR Perwien DE Faries CJ Kratochvil CR Sumner DK Kelsey AJ Allen 2004 Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies of atomoxetine Dev Behav Pediatr 25 4 264 271 10.1097/00004703-200408000-00006 (Pubitemid 39199572)
30. AR Perwien CJ Kratochvil DE Faries BS Vaughan T Spencer RT Brown 2006 Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality of life outcomes? J Child Adolesc Psychopharmacol 16 6 713 724 10.1089/cap.2006.16.713 17201615
31. Poznaski E, Mokros HB (1999) Children's depression rating scale, revised. (CDRS-R). Western Psychological Services, Los Angeles
32. S Prasad V Harpin L Poole H Zeitlin S Jamdar K Puvanendran 2007 A multi-centre, randomized, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention deficit/hyperactivity disorder (ADHD) Curr Med Res Opin 23 2 379 394 10.1185/030079906X167309 1:CAS:528:DC%2BD2sXjsVOgs7s%3D 17288692 (Pubitemid 46333386)
33. Ralston SJ, Lorenzo M, ADORE Study Group (2004) ADORE-attention-deficit hyperactivity disorder observational research in Europe. Eur Child and Adolesc Psychiatry (Suppl 1) I/36-I/42
34. H Remschmidt Global ADHD Working Group 2005 Global consensus on ADHD/HKD Eur Child Adolesc Psychiatry 14 3 127 137 10.1007/s00787-005-0439-x 15959658
35. AW Riley KS Chan S Prasad L Poole 2007 A global measure of child health-related quality of life: reliability and validity of the child health and illness profile-child editon (CHIP-CE) global score J Med Econ 10 91 106
36. AW Riley D Coghill CB Forrest MJ Lorenzo SJ Ralston G Spiel 2006 Validity of the health-related quality of life assessment in the ADORE study: parent report form of the CHIP-CE edition Eur Child Adolesc Psychiatry 15 Suppl 1 I/63 I/71
37. AW Riley CB Forrest B Starfield GW Rebok JA Robertson BF Green 2004 The parent report form of the CHIP-Child edition: reliability and validity Med Care 42 3 210 220 10.1097/01.mlr.0000114909.33878.ca 15076820
38. AW Riley LM Lyman G Spiel M Döpfner MJ Lorenzo SJ Ralston 2006 The family strain index (FSI). Reliability, validity, and factor structure of a brief questionnaire for families of children with ADHD Eur Child Adolesc Psychiatry 15 Suppl 1 I/72 I/78
39. P Svanborg G Thernlund PA Gustafssson B Hägglöf L Poole B Kadesjö 2009 Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder-a randomized, double-blind, placebo-controlled study in Swedish children and adolescents Eur Child Adolesc Psychiatry 18 240 249 10.1007/s00787-008-0725-5 10.1007/s00787-008-0725-5 19156355
40. UK Strattera SPC (2007)
41. M Weiss R Tannock C Kratochvil D Dunn J Velez-Borras C Thomason R Tamura D Kelsey L Stevens AJ Allen 2005 A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD J Am Acad Child Adolesc Psychiatry 44 647 655 10.1097/01.chi.0000163280.47221.c9 15968233 (Pubitemid 40875359)